BUSINESS

• Meiji, NCC Launch Research on Self-Amplifying mRNA Cancer Vaccine
  November 13, 2025

• Bayer, Regeneron Move to Block Fuji’s Newly Listed Eylea Biosimilar in Japan
  November 13, 2025

• J&J Japan Targets Top Share in Key Disease Areas by 2030: New President
  November 12, 2025

• Biogen Launches Higher-Dose Spinraza in Japan
  November 12, 2025

• Meiji Pharma to Set Up Singapore Subsidiary to Drive ASEAN Biz
  November 12, 2025

• Alfresa Deepens Tie-Up with China Wholesaler to Support Japan-to-China Licensing
  November 12, 2025

• Japan’s Generic, Biosimilar Market Seen Topping 2 Trillion Yen in 2033: Fuji Keizai
  November 12, 2025

• Japan Ethical Drug Sales Jump 9.7% in September: Crecon
  November 11, 2025

• Kaken’s KP-001 Hits Goal in PIII Vascular Malformation Trial
  November 11, 2025

• MSD Japan Chief Voices Regret over Delay in Routine HPV Shots for Males
  November 10, 2025

• J&J Files Oral Psoriasis Drug Icotrokinra in Japan
  November 10, 2025

• Keytruda Still Dominates Japan Drug Market in October: Encise
  November 10, 2025

• Xarelto AG Logs 9.6 Billion Yen on NHI Basis in April-September: Qol
  November 10, 2025

• MSD Seeks Capvaxive Use in High-Risk Children in Japan
  November 10, 2025

• Eisai Settles Lenvima Patent Case with India’s Torrent
  November 10, 2025

• Nipro, Nichi-Iko to Consolidate Injectable Antibiotics Production by 2026
  November 7, 2025

• Teijin Debuts Yorvipath in Japan, Eyes Rare Disease Growth
  November 7, 2025

• Genmab Seeks Label Expansion for Epkinly Combo Use in Japan
  November 7, 2025

• Alfresa, K Pharma Tie Up on iPS Cell-Derived Therapy KP8011
  November 7, 2025

• Fujifilm to Launch ADC-Focused CDMO Services First in Japan
  November 7, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• …
• Next ›
• 最終 »